PuSH - Publikationsserver des Helmholtz Zentrums München

Stalder, J.F.* ; Barbarot, S.* ; Wollenberg, A.* ; Holm, E.A.* ; de Raeve, L.* ; Seidenari, S.* ; Oranje, A.* ; Deleuran, M.* ; Cambazard, F.* ; Svensson, A.* ; Simon, D.* ; Benfeldt, E.* ; Reunala, T.* ; Mazereeuv, J.* ; Boralevi, F.* ; Kunz, B.* ; Misery, L.* ; Mortz, C.G.* ; Darsow, U. ; Gelmetti, C.* ; Diepgen, T.* ; Ring, J. ; Moehrenschlager, M.* ; Gieler, U.* ; Taïeb, A.* ; PO-SCORAD Investigators (*)

Patient-oriented SCORAD (PO-SCORAD): A new self-assessment scale in atopic dermatitis validated in Europe.

Allergy 66, 1114-1121 (2011)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
BACKGROUND: Patient-oriented medicine is an emerging concept, encouraged by the World Health Organization, to greater involvement of the patient in the management of chronic diseases. The Patient-Oriented SCORing Atopic Dermatitis (PO-SCORAD) index is a self-assessment score allowing the patient to comprehensively evaluate the actual course of atopic dermatitis (AD), using subjective and objective criteria derived mainly from the SCORAD, a validated AD severity clinical assessment tool. OBJECTIVES: To validate the PO-SCORAD index in a large European population of patients exhibiting all forms of AD severity by assessing its correlation with the SCORAD index. PATIENTS/METHODS: Four hundred and seventy-one patients (185 adults, 286 children) consulting for AD in hospitals from 9 European countries were recruited. The investigators and the patients used the SCORAD and PO-SCORAD scales, respectively, to assess AD severity at inclusion (D0) and 28 ± 7 days later (D28). RESULTS: Patient-Oriented SCORing Atopic Dermatitis and SCORAD scores were significantly correlated at D0 [r = 0.67 (95% CI: 0.62; 0.72), P < 0.0001]. Consistency was confirmed at D28, with a stronger linear correlation between both scales [r = 0.79 (95% CI: 0.75; 0.83), P < 0.0001]. Absolute changes from baseline in SCORAD and PO-SCORAD scores were also significantly correlated [r= 0.71 (95% CI: 0.64; 0.76), P < 0.0001]. Although no specific intervention was investigated, AD improved over the study, with a decrease of PO-SCORAD and SCORAD scores from D0 to D28 by -19.19% and -24.39%, respectively. The consistency of the correlations was similar in the adult and children groups. CONCLUSIONS: This study validated the use of PO-SCORAD to self-assess AD severity and demonstrated its good correlation with SCORAD.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter atopic dermatitis (MesH); eczema score; patient-oriented; SCORing of Atopic Dermatitis index; self-assessment score
ISSN (print) / ISBN 0105-4538
e-ISSN 1398-9995
Zeitschrift Allergy
Quellenangaben Band: 66, Heft: 8, Seiten: 1114-1121 Artikelnummer: , Supplement: ,
Verlag Wiley
Verlagsort Malden, MA
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Lung Health and Immunity (LHI)
Institute of Epidemiology (EPI)